Form 8-K - Current report:
SEC Accession No. 0000200406-26-000089
Filing Date
2026-04-28
Accepted
2026-04-27 17:33:52
Documents
12
Period of Report
2026-04-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20260423.htm   iXBRL 8-K 81639
  Complete submission text file 0000200406-26-000089.txt   299260

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20260423.xsd EX-101.SCH 4583
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20260423_def.xml EX-101.DEF 10568
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20260423_lab.xml EX-101.LAB 38371
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20260423_pre.xml EX-101.PRE 22234
15 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20260423_htm.xml XML 10683
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 26902320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)